Log in

Relevant bibliographies by topics / Acute and chronic bronchitis / Journal articles

To see the other types of publications on this topic, follow the link: Acute and chronic bronchitis.

Journal articles on the topic 'Acute and chronic bronchitis'

Author: Grafiati

Published: 4 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Acute and chronic bronchitis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Gallis, Harry A. "ACUTE BRONCHITIS AND ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS." Infectious Diseases in Clinical Practice 3, no. 2 (1994): 81–86. http://dx.doi.org/10.1097/00019048-199403000-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Brown, Richard B. "Acute and chronic bronchitis." Postgraduate Medicine 85, no. 8 (1989): 249–54. http://dx.doi.org/10.1080/00325481.1989.11700754.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

CARBON, CLAUDE. "Acute and Chronic Bronchitis." Microbial Drug Resistance 1, no. 2 (1995): 159–62. http://dx.doi.org/10.1089/mdr.1995.1.159.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Saleem, Sufyan, Kashif Sardar, and Nasir Javed. "CHRONIC BRONCHITIS." Professional Medical Journal 25, no. 08 (2018): 1240–44. http://dx.doi.org/10.29309/tpmj/18.4936.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Balter, Meyer, and Ronald F. Grossman. "Management of chronic bronchitis and acute exacerbations of chronic bronchitis." International Journal of Antimicrobial Agents 9, no. 2 (1997): 83–93. http://dx.doi.org/10.1016/s0924-8579(97)00034-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Saleem, Sufyan, Kashif Sardar, and Nasir Javed. "CHRONIC BRONCHITIS;." Professional Medical Journal 25, no. 08 (2018): 1240–44. http://dx.doi.org/10.29309/tpmj/2018.25.08.66.

Full text

Abstract:

Chronic bronchitis is chronic inflammation of the airways resulting from exposureto noxious particles and gases which is slowly progressive and accentuated by episodes of acuteexacerbation. These exacerbations tend to become more frequent and more severe as the underlyingdisease advances resulting in increased morbidity. More than half of these exacerbations are dueto bacterial infections and use of antibiotics in such cases result in early recovery. Moxifloxacinis a newer fluoroquinolone that is very effective against respiratory pathogens including atypicalorganisms and even in resistant pat

APA, Harvard, Vancouver, ISO, and other styles

7

Obaji, Adel, and Sanjay Sethi. "Acute Exacerbations of Chronic Bronchitis." Drugs & Aging 18, no. 1 (2001): 1–11. http://dx.doi.org/10.2165/00002512-200118010-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Morris, Stephen, Pippa Anderson, and Debra E. Irwin. "Acute Exacerbations of Chronic Bronchitis." PharmacoEconomics 20, no. 3 (2002): 153–68. http://dx.doi.org/10.2165/00019053-200220030-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Ball, Peter. "Acute exacerbations of chronic bronchitis." Current Opinion in Infectious Diseases 13, no. 2 (2000): 171–76. http://dx.doi.org/10.1097/00001432-200004000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Verghese, Abraham, and Hassan M. Ismail. "Acute exacerbations of chronic bronchitis." Postgraduate Medicine 96, no. 8 (1994): 75–89. http://dx.doi.org/10.1080/00325481.1994.11945938.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Aboussouan, Loutfi S. "Acute exacerbations of chronic bronchitis." Postgraduate Medicine 99, no. 4 (1996): 89–104. http://dx.doi.org/10.1080/00325481.1996.11946098.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Ball, Peter, and Barry Make. "Acute Exacerbations of Chronic Bronchitis." Chest 113, no. 3 (1998): 199S—204S. http://dx.doi.org/10.1378/chest.113.3_supplement.199s.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Watanakunakorn, Chatrchai. "Acute Exacerbation of Chronic Bronchitis." Chest 118, no. 6 (2000): 1523–25. http://dx.doi.org/10.1378/chest.118.6.1523-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Grossman, Ronald F. "Acute Exacerbations of Chronic Bronchitis." Hospital Practice 32, no. 10 (1997): 85–94. http://dx.doi.org/10.1080/21548331.1997.11443581.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Kim, Namjin, and Kenneth V. Leeper, Jr. "Epidemiology of Chronic Bronchitis and Acute Infective Exacerbations of Chronic Bronchitis." Seminars in Respiratory and Critical Care Medicine 21, no. 2 (2000): 0073–78. http://dx.doi.org/10.1055/s-2000-9845.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Trevisani, Lucio, Sergio Sartori, Stefano Putinati, Giorgio Stabellini, and Vincenzo Abbasciano. "Antibiotics in Acute Bronchitis and Exacerbations of Chronic Bronchitis." Chest 111, no. 6 (1997): 1788–89. http://dx.doi.org/10.1378/chest.111.6.1788.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

McGhie, D., P. Kerfoot, and D. J. Talbot. "A Comparative Study of Miraxid (Pivmecillinam plus Pivampicillin) and Augmentin (Amoxycillin plus Clavulanic Acid) in the Treatment of Lower Respiratory Tract Infections in General Practice." Journal of International Medical Research 14, no. 5 (1986): 254–60. http://dx.doi.org/10.1177/030006058601400505.

Full text

Abstract:

Two treatments, a) pivmecillinam 200 mg plus pivampicillin 250 mg (Miraxid*) given twice-daily and b) amoxycillin 250 mg plus clavulanic acid 125 mg (Augmentin*) given three times daily were compared in two parallel groups of 388 general practice patients with acute bronchitis or acute exacerbations of chronic bronchitis. Patients with acute bronchitis (140 on Miraxid, 144 on Augmentin) received a 7-day course of treatment and those with acute exacerbations of chronic bronchitis (55 on Miraxid, 49 on Augmentin) a 10-day course of treatment. Both treatments were equally effective, with 99 (71%)

APA, Harvard, Vancouver, ISO, and other styles

18

Pedro, Gerardo San, and Ronald George. "Treating Acute Exacerbations of Chronic Bronchitis." Hospital Practice 35, no. 11 (2000): 43–50. http://dx.doi.org/10.3810/hp.2000.11.219.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Chodosh, Sanford. "Acute Bacterial Exacerbation of Chronic Bronchitis." Clinical Drug Investigation 9, Supplement 1 (1995): 25–29. http://dx.doi.org/10.2165/00044011-199500091-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Braman, Sidney S. "Chronic Cough Due to Acute Bronchitis." Chest 129, no. 1 (2006): 95S—103S. http://dx.doi.org/10.1378/chest.129.1_suppl.95s.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Yudina, Liudmyla. "Chronic Cough: How to Help the Patient?" Family Medicine, no. 4 (October 5, 2016): 112–16. https://doi.org/10.30841/2307-5112.4.2016.248555.

Full text

Abstract:

Cough is one of the most important symptoms and it is a characteristic for many lung diseases. It often reduces the patient's quality of life. The article presents positive results of studies of the effect on mucociliary clearance, efficacy and safety of using the drug GeloMyrtol® Forte for the prevention and treatment of acute and chronic diseases of the upper and lower respiratory tract. Good tolerability allows you to help patients not only with acute but also with a chronic cough.

APA, Harvard, Vancouver, ISO, and other styles

22

Kapustina, V. A., and S. I. Ovcharenko. "Antibacterial inhalation therapy with thiamphenicol glycinate acetylcysteinate in pulmonology." Russian Pulmonology 28, no. 4 (2018): 483–89. http://dx.doi.org/10.18093/0869-0189-2018-28-4-483-489.

Full text

Abstract:

Thiamphenicol glycinate acetylcysteinate (TGA) is a combination of thiamphenicol, a broad-spectrum antibiotic, and mucolytic drug N-acetylcysteine. This article is a review of pharmacological, microbiological, and clinical effects of this combined drug. Inhaled TGA could be considered as a worthy alternative for oral mucolytics and oral antibiotics in treatment of upper and lower airway diseases, such as acute and chronic rhinosinusitis, otitis media, tonsillitis, acute bronchitis, and acute exacerbation of chronic bronchitis and chronic obstructive pulmonary disease, in children and adults.

APA, Harvard, Vancouver, ISO, and other styles

23

Dr.Ahmed, Saeed Alzahrani Dr.Fahad Ayesh Almutairi Dr.mohammed thabet alharthi Dr.Turki Saleh Almajnoni Dr.Marwai Mohammed Mahnashi Dr.Shaker Hammad Alsaadi Dr.Abdullah Saeed Al-Ghamdi. "ROLES OF FAMILY PHYSICIANS IN THE MANAGEMENT OF ACUTE BRONCHITIS IN PRIMARY CARE." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 06, no. 01 (2019): 628–35. https://doi.org/10.5281/zenodo.2533327.

Full text

Abstract:

<em>Acute bronchitis is one of the commonest medical problems managed by health services, and one of the important clinical questions is how to diagnose it in primary care, and differentiate from other disease and careful step of management to resolve disease. In this review we discuss management strategies by family doctor. Electronic databases (PubMed/ Embase) were searched up to NOVEMBER, 2018, for relevant literature in the management of Acute bronchitis in primary care by family doctors.  Acute bronchitis is a widespread disease identified by fever and coughing that is usually wheezy

APA, Harvard, Vancouver, ISO, and other styles

24

Chock, Alan, Vera Gong, and Christopher J. Destache. "Antibacterials and Acute Exacerbation of Chronic Bronchitis." Disease Management & Health Outcomes 10, no. 6 (2002): 333–36. http://dx.doi.org/10.2165/00115677-200210060-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Maesen, F. P. V., B. I. Davies, and J. P. Teengs. "Pefloxacin in acute exacerbations of chronic bronchitis." Journal of Antimicrobial Chemotherapy 16, no. 3 (1985): 379–88. http://dx.doi.org/10.1093/jac/16.3.379.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Hoogkamp-Korstanje, J. A. A., and S. J. Klein. "Ciprofloxacin in acute exacerbations of chronic bronchitis." Journal of Antimicrobial Chemotherapy 18, no. 3 (1986): 407–13. http://dx.doi.org/10.1093/jac/18.3.407.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Stockley, Robert A. "Inflammation and Acute Exacerbations of Chronic Bronchitis." Chest 120, no. 4 (2001): 1422–23. http://dx.doi.org/10.1378/chest.120.4.1422.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Sethi, Sanjay, and Timothy F. Murphy. "Inflammation and Acute Exacerbations of Chronic Bronchitis." Chest 120, no. 4 (2001): 1423. http://dx.doi.org/10.1016/s0012-3692(16)35563-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Sethi, Sanjay. "Antibiotics in acute exacerbations of chronic bronchitis." Expert Review of Anti-infective Therapy 8, no. 4 (2010): 405–17. http://dx.doi.org/10.1586/eri.09.133.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Sethi, Sanjay. "MANAGEMENT OF ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS." Infectious Diseases in Clinical Practice 7, Supplement 5 (1998): S300—S308. http://dx.doi.org/10.1097/00019048-199812005-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Kassner, Nina, Meinolf Wonnemann, Yvonne Ziegler, Rainer Stange, and Karel Kostev. "Investigation into the Effectiveness of an Herbal Combination (Angocin®Anti-Infekt N) in the Therapy of Acute Bronchitis: A Retrospective Real-World Cohort Study." Antibiotics 13, no. 10 (2024): 982. http://dx.doi.org/10.3390/antibiotics13100982.

Full text

Abstract:

Background: The goal of this study was to evaluate whether the medical recommendation of Angocin®Anti-Infekt N (heretofore referenced as Angocin®) on the day of diagnosis of acute bronchitis is negatively associated with the recurrence of acute bronchitis diagnosis, antibiotic prescriptions, incidence of chronic bronchitis, and duration of sick leave. Methods: This study included patients in general practices in Germany with a first documented diagnosis of acute bronchitis between 2005 and 2022 (index date) and a prescription of Angocin®, thyme products, essential oils, mucolytics or antibioti

APA, Harvard, Vancouver, ISO, and other styles

32

Havrylenko, Anastasiia, and Oleksandr Smiyan. "INFORMATION ON PROGNOSTIC MARKERS OF SEVERE ACUTE BRONCHITIS IN PRESCHOOLERS: A STUDY IN SUMY REGION IN NORTH-EASTERN UKRAINE." Eastern Ukrainian Medical Journal 11, no. 4 (2023): 408–20. http://dx.doi.org/10.21272/eumj.2023;11(4):408-420.

Full text

Abstract:

Introduction. Respiratory infections, especially in children, are a significant global health concern. Understanding the implications of respiratory infections like acute bronchitis is crucial for devising effective management strategies. These infections, including bronchitis, pneumonia, and influenza, contribute substantially to pediatric hospitalizations. Predicting the severity of acute bronchitis in children is essential for personalized treatment and resource allocation. Developing reliable prognostic tools for acute bronchitis can improve outcomes and optimize healthcare resource utiliz

APA, Harvard, Vancouver, ISO, and other styles

33

Vizel, А. A., R. F. Khamitov, E. D. Gizatullina, et al. "Efficiency of ambrosan in bronchopulmonary diseases." Kazan medical journal 80, no. 3 (1999): 179–83. http://dx.doi.org/10.17816/kazmj66684.

Full text

Abstract:

As many as 137 patients with acute and chronic bronchitis, pneumonia, bronchial asthma, bron- choectatic disease and tuberculosis were given ambrosan in a dose of 30 mg three times per day in combined therapy (all patients were given antibacterial drugs). It was shown that ambrosan softens cough, promotes sputum passage, positively affects rhe bronchopulmonary disease course. This effect was the most pronounced in acute and chronic bronchitis (87% and 94,8%).

APA, Harvard, Vancouver, ISO, and other styles

34

Alharbi, Samar, Abdullah Alshehri, Sayed Neama, et al. "An Overview of Acute Bronchitis and Upper Respiratory Tract Infections." Journal of Healthcare Sciences 03, no. 01 (2023): 58–63. http://dx.doi.org/10.52533/johs.2023.30110.

Full text

Abstract:

A variety of viruses and bacteria can cause upper respiratory tract infections. These cause a variety of patient diseases including acute bronchitis, the common cold, influenza, and respiratory distress syndromes. Defining most of these patient diseases is difficult because the presentations connected with upper respiratory tract infections commonly overlap and their causes are similar. Upper respiratory tract infections are characterized as self-limiting irritation and oedema of the upper respiratory tract, along with coughing and no evidence of pneumonia, in a patient without a background of

APA, Harvard, Vancouver, ISO, and other styles

35

Khamitova, E. G., R. F. Khamitov, and A. K. Zakirova. "Changes in the activity of enzymes in the blood in nonspecific lung diseases." Kazan medical journal 81, no. 3 (2022): 172–75. http://dx.doi.org/10.17816/kazmj96697.

Full text

Abstract:

Level of different ensymes was determined in blood serum of patients with bronchial asthma, chronic obstructive bronchitis, chronic nonobstructive bronchitis, pneumonia and 22 healthy persons. In severe chronic obstructive bronchitis in contrast to bronchial asthma, the increase of activity in blood serum was found which can serve as a differential and diagnostic indicator. In the acute phase of pneumonia and severe chronic nonobstructive bronchitis the increase of alkaline phosphatase, gamma-glutanul transferase activities occurred, and in pneumonia activity of aminotransferases increased as

APA, Harvard, Vancouver, ISO, and other styles

36

Sahu, Tokeshwar. "People with Chronic Bronchitis are at More Risk of Getting COVID-19." ECS Transactions 107, no. 1 (2022): 16359–68. http://dx.doi.org/10.1149/10701.16359ecst.

Full text

Abstract:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the seventh-generation coronavirus family causing viral pandemic coronavirus disease (COVID-19) across the globe, affecting millions of people. In this time, the COVID-19 coronavirus pandemic is a worldwide problem that affects 10.8M people (3 Feb. 2021). The cases of COVID-19 increase daily and affect our physical, mental, and social-economic conditions. The recent outbreak of coronavirus disease 2019 (COVID-19), triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses an enormous threat to global publ

APA, Harvard, Vancouver, ISO, and other styles

37

Malhotra, Harinder S., Caroline M. Perry, and Douglas Ormrod. "Management of Acute Bacterial Exacerbations of Chronic Bronchitis." Disease Management and Health Outcomes 10, no. 1 (2002): 55–70. http://dx.doi.org/10.2165/00115677-200210010-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

&NA;. "Ciprofloxacin preferable for acute exacerbations of chronic bronchitis." Inpharma Weekly &NA;, no. 1221 (2000): 5. http://dx.doi.org/10.2165/00128413-200012210-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Hayes, Don, and Keith C. Meyer. "Acute Exacerbations of Chronic Bronchitis in Elderly Patients." Drugs & Aging 24, no. 7 (2007): 555–72. http://dx.doi.org/10.2165/00002512-200724070-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Zhang, M., B. Peng, J. Niehus, et al. "Kinin generation in acute pneumonia and chronic bronchitis." European Respiratory Journal 10, no. 8 (1997): 1747–53. http://dx.doi.org/10.1183/09031936.97.10081747.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

ADAMS, S. "Antibiotic therapy in acute exacerbations of chronic bronchitis." Seminars in Respiratory Infections 15, no. 3 (2000): 234–47. http://dx.doi.org/10.1053/srin.2000.18077.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Sethi, Sanjay. "Infectious Etiology of Acute Exacerbations of Chronic Bronchitis." Chest 117, no. 5 (2000): 380S—385S. http://dx.doi.org/10.1378/chest.117.5_suppl_2.380s.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Niederman, Michael S., Jeffrey S. McCombs, Alan N. Unger, Amit Kumar, and Robert Popovian. "Treatment cost of acute exacerbations of chronic bronchitis." Clinical Therapeutics 21, no. 3 (1999): 576–91. http://dx.doi.org/10.1016/s0149-2918(00)88310-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Laohaburanakit, Petey. "Antibiotic Use in Acute Exacerbations of Chronic Bronchitis." Chest 132, no. 6 (2007): 2063. http://dx.doi.org/10.1378/chest.07-2131.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Davies, B. I., F. P. V. Maesen, H. L. L. Gubbelmans, and H. M. H. G. Cremers. "Temafloxacin in acute purulent exacerbations of chronic bronchitis." Journal of Antimicrobial Chemotherapy 26, no. 2 (1990): 237–46. http://dx.doi.org/10.1093/jac/26.2.237.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Meyer, Richard D. "CONSIDERATIONS FOR MANAGING ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS." Infectious Diseases in Clinical Practice 7, Sup 4 (1998): S263—s268. http://dx.doi.org/10.1097/00019048-199811004-00011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Siempos, Ilias I., Argyris Michalopoulos, and Matthew E. Falagas. "Treatment of acute bacterial exacerbations of chronic bronchitis." Expert Opinion on Pharmacotherapy 10, no. 7 (2009): 1173–82. http://dx.doi.org/10.1517/14656560902907734.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

El-Sayed, Zienab F., and Radia Abd El-Sattar. "Nursing Intervention for Mothers Having Children Suffering from Acute Bronchitis." Evidence-Based Nursing Research 2, no. 1 (2020): 12. http://dx.doi.org/10.47104/ebnrojs3.v2i1.114.

Full text

Abstract:

Context: Acute bronchitis is one of the most common causes of chronic respiratory diseases in childhood with a significant impact on children. Aim: The study aimed to evaluate the effect of nursing intervention on mothers' knowledge and practices regarding caring for their children suffering from acute bronchitis. Methods: A quasi-experimental design (one group pre/post-test). The study was conducted at the Pediatric Emergency Department and Outpatient clinic in children's hospital affiliated to Ain Shams University Hospitals. A convenient sample of 52 children newly diagnosed with

APA, Harvard, Vancouver, ISO, and other styles

49

Li, Gukun. "Clinical Effect of Integrated Chinese and Western Medicine in Treating Chronic Bronchitis and Complicated with Emphysema." Highlights in Science, Engineering and Technology 30 (February 15, 2023): 215–19. http://dx.doi.org/10.54097/hset.v30i.5231.

Full text

Abstract:

Chronic bronchitis is a chronic inflammatory disease caused by lung dysfunction caused by various causes. Clinically, the main manifestations are chronic cough, sputum cough and chest tightness and other symptoms, and accompanied by emphysema in patients with dyspnea, cough and asthma are more obvious. According to statistics, the prevalence rate of Chinese adults is 4.2%~6.4%. At present, the research on chronic bronchitis complicated with emphysema at home and abroad is still in the early stage or mainly in the acute attack stage, which is mostly related to the long-term use of non-steroidal

APA, Harvard, Vancouver, ISO, and other styles

50

Artemyeva, E. G., E. A. Lisitsin, and A. M. Sveklov. "D1namics of the content of histamine, serotonin, catecholamines of bronchi mucous membranes in acute bronchitis of the lingering course." Kazan medical journal 80, no. 4 (1999): 247–49. http://dx.doi.org/10.17816/kazmj70088.

Full text

Abstract:

The results of examination and treatment of 30 patients with acute bronchitis of the lingering course are presented. It is established that the level of histamine and serotonin in alveolar macrophages, lymphocytes, neutrophiles, APUD-cells is reliably higher and the content of catecholamines is lower than in healthy persons. The indicators given can be used as an additional criterion of the pathologic process activity on the one hand as well as a sign of transforming acute bronchitis of the lingering course into chronic bronchitis on the other hand.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!